Envista (NVST) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
19 May, 2026Opening remarks and agenda
Meeting called to order at 7:00 A.M. Pacific Time on May 19, 2026, with introductions of board members and officers.
Business portion conducted first, followed by a Q&A session for stockholders.
Record date for voting set as March 23, 2026, with 162,980,850 shares outstanding.
Board and executive committee updates
Board members and committee chairs introduced, including Compensation, Audit, and Nominating Governance Committees.
Officers present included the CFO and General Counsel, with roles in Q&A and meeting procedures.
Shareholder proposals
Four proposals presented: election of directors, ratification of auditors, advisory vote on executive compensation, and frequency of future advisory votes.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Envista
- Strong Q1 2026 growth, margin expansion, and $300M buyback; guidance reaffirmed.NVST
Q1 202612 May 2026 - Double-digit core sales, EBITDA, and EPS growth in 2025, with strong 2026 outlook.NVST
Q4 202516 Apr 2026 - Key votes include director elections, auditor ratification, and executive pay approval.NVST
Proxy filing7 Apr 2026 - Annual meeting to vote on directors, auditor, executive pay, and ESG priorities.NVST
Proxy filing7 Apr 2026 - Targets 2%-4% core growth and 7%-10% EPS growth, driven by innovation and operational discipline.NVST
CMD 20253 Feb 2026 - Q2 loss of $1.15B on impairments; sales, margins fell, but cash flow and Q4 outlook improved.NVST
Q2 20242 Feb 2026 - Q3 2024 sales fell 5.3%, net income dropped, but full-year guidance was reaffirmed.NVST
Q3 202417 Jan 2026 - Dental market growth, innovation, and operational execution drive double-digit financial gains.NVST
44th Annual J.P. Morgan Healthcare Conference13 Jan 2026 - Stable dental market, growth investments, and China VBP shape outlook for 2025.NVST
7th Annual Evercore ISI HealthCONx Conference12 Jan 2026